Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

NCT04673266

Conditions
Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activites) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Completed

A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

NCT03984097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Pacific Cancer Care Monterey, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT04488354

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

NCT04102020

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mitchell Cancer Institute /ID# 216443 Mobile, Alabama, United States
  • Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156 Fountain Valley, California, United States
  • University of California, Los Angeles /ID# 219149 Los Angeles, California, United States
  • Colorado Blood Cancer Institute /ID# 214280 Denver, Colorado, United States
View all 156 locations
View Trial Details

Related conditions